Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 2281 - 2288 of 12086 results
No Second H-1B Lottery: 2022 H-1B Cap Lottery Has Been Completed
August 22, 2022| Alert| Viewpoint
SNCJ Deep Dive: CA Takes Another Swing at Gender Pay Equity
August 22, 2022| News
Examining the Future of Telehealth in America: What a White House Report Recommends
August 22, 2022| Podcast| Viewpoint
Webinar: The Inflation Reduction Act - Are You Ready?
August 19, 2022| Webinar| Viewpoint
Artificial Intelligence and Intellectual Property
August 19, 2022| News
FTC Policy Paper Supports Agency’s Long-Held Position in Opposition to COPAs
August 18, 2022| Alert| Viewpoint
“Commercial Surveillance” Questions Take Center Stage at the Federal Trade Commission
August 18, 2022| Blog| Viewpoint
Eighth Circuit Adopts Stricter But-For Causation Standard for False Claims Act Claims based on Anti-Kickback Violations
August 18, 2022| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|